IMPACT Therapeutics, an innovative pharmaceutical company specializing in targeted cancer therapeutics, has announced a significant funding milestone, successfully raising $34.5 million in its latest investment round. Founded with a mission to develop proprietary, groundbreaking anti-cancer drugs, IMPACT Therapeutics focuses on synthetic lethality mechanisms, aiming to transform the landscape of cancer treatment. The company boasts one of the most comprehensive DNA Damage Repair (DDR) product portfolios in the global biopharmaceutical sector, leveraging its in-house research to address critical deficiencies in existing treatment options. The newly acquired funding will be pivotal in accelerating the company's ongoing research and development initiatives, particularly as it seeks to expand its product offerings in the realm of synthetic lethality targets. This capital infusion will not only bolster IMPACT's efforts in advancing existing therapies towards clinical trials, but it will also enable the exploration of new avenues of research that promise to enhance patient outcomes in the fight against cancer. With a commitment to innovation and patient-centric solutions, IMPACT Therapeutics is poised to make significant strides in the biopharmaceutical industry, marking a pivotal moment in its journey to deliver effective, targeted treatments for cancer patients worldwide. The company鈥檚 visionary approach and robust funding position it favorably for future growth and breakthroughs in the field of oncology.
IMPACT Therapeutics Secures $34.5 Million in Funding for Groundbreaking Cancer Drug Innovation
Recently funded 路 $34.5MPharmaceuticals
Get the full IMPACT Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
